Radiofrequency tissue volume reduction for treatment of auricle keloids

Laryngoscope. 2011 Jun;121(6):1233-6. doi: 10.1002/lary.21782. Epub 2011 May 6.

Abstract

Objectives/hypothesis: Keloids are often refractive to treatment, and recurrences occur quite frequently. Radiofrequency tissue volume reduction (RFTVR) is a surgical technology that induces extensive fibrosis at the target tissues.

Methods: We applied RFTVR in 14 patients (19 auricles, 5 patients treated bilaterally; 9 female, 5 male; range, 10-66 years) with keloids of the auricle. Keloids were located at the earlobe in 4 patients (5 auricles), helix in 9 patients (12 auricles), and at both earlobe and helix in 1 patient (2 auricles). In 6 patients (8 auricles) RFTVR was the sole treatment modality applied, and in 7 patients (10 auricles) intralesional steroid injection was also performed. Patients underwent one to seven sessions of RFTVR. Patients were followed up between 2 and 92 months postoperatively (median, 24.5 months).

Results: Good cosmetic results were achieved in 10 of 14 patients (13 auricles). Three patients (5 auricles) were refractive to treatment, and 1 patient (1 auricle) showed progressive disease despite treatment.

Conclusions: Radiofrequency tissue volume reduction may be considered as a new, minimally invasive treatment option for keloids of the auricle.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Catheter Ablation / methods
  • Child
  • Ear Auricle / surgery*
  • Ear Diseases / surgery*
  • Female
  • Humans
  • Keloid / surgery*
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Young Adult